Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Diabetes subtypes

Different influence on erectile dysfunction

    • Endocrinology and Diabetology
    • General Internal Medicine
    • RX
    • Urology
  • 2 minute read

A study by the German Diabetes Center found not only that diabetes increases the risk of erectile dysfunction in men, but also that there are differences in its occurrence between different diabetes subtypes. What exactly are the findings? Does this allow conclusions to be drawn about future therapies?

As men age, they may experience erectile dysfunction. However, a diabetes condition can additionally increase this risk. The fact that erectile dysfunction occurs more frequently in type 2 diabetes than in type 1 diabetes now aroused the interest of researchers at the German Diabetes Center (DDZ). To review how common erectile dysfunction is in the new subtypes of diabetes and what conclusions can be drawn for any therapies.

In the meantime, scientists are increasingly coming to the conclusion that there are not just type 1 and type 2 diabetes, but five subtypes, some of which can have very different effects on those affected. These five subtypes can be classified as follows:

  • Severe autoimmune diabetes (SAID); corresponds to classic type 1 diabetes
  • Severe insulin-deficient diabetes (SIDD)
  • Severe Insulin Resistance-Responsive Diabetes (SIRD).
  • Moderate overweight diabetes (MOD)
  • Moderate age-related diabetes (MARD)

“People with insulin-deficient diabetes, for example, are more likely to show disturbed pain sensations such as tingling or numbness in their hands and feet, while those with severe insulin-resistant diabetes are at higher risk of liver and kidney disease,” explains Prof. Dr. Michael Roden, Scientific Director and Chairman of the DDZ, and continues. “The aim of our new study was therefore to characterize the frequency of erectile dysfunction in these five subtypes of diabetes.” To this end, more than 350 men aged 18 to 69 years with newly diagnosed diabetes were studied as part of the German Diabetes Study. An additional 124 men from the German Diabetes Study without diabetes were included as a control group.

First, it showed that 23 percent of all men with diabetes studied suffered from erectile dysfunction – compared with only 11 percent of men without diabetes. Compared with the subjects without erectile dysfunction, the affected subjects were also older, had a higher body mass index (BMI), higher triglyceride levels, and lower cholesterol levels. “It is interesting to note, however, that the frequency of dysfunctions was highest in individuals with severe insulin resistance-associated diabetes (SIRD), at 52 percent. In contrast, they were lowest in severe autoimmune diabetes (SAID) at 7 percent,” said Dr. Haifa Maalmi, a research associate in the Inflammation Research Group at DDZ, summarizing the results. “This suggests that the incidence of erectile dysfunction differs between diabetes subtypes.”

Since in addition to SIRD subtype, SIDD subtype also has a relatively high risk of erectile dysfunction in men, insulin deficiency as well as insulin resistance can be considered as major factors. “Therefore, the next step should be to specifically examine these two subtypes for erectile dysfunction,” says Prof. Christian Herder, MD, deputy director at the Institute of Clinical Diabetology. “If the underlying mechanisms are better understood here, therapies can also be more targeted.”

 

Source: 

Maalmi H, et al: Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes. Diabetolo-gia 2022; 65(3):552-562. DOI: 10.1007/s00125-021-05607-z.

 

Previous Article
  • Multiple sclerosis

S1P receptor modulators in RRMS: tailored therapy management

  • CME continuing education
  • Education
  • Neurology
  • Pharmacology and toxicology
  • RX
  • Studies
  • Training with partner
View Post
Next Article
  • Diabetes

Pain is not equal to pain

  • Endocrinology and Diabetology
  • General Internal Medicine
  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 12 min
  • Multidrug-Resistant Pathogens in Wound Care

An Enemy in the Microbiome?

    • Dermatology and venereology
    • CME continuing education
    • Infectiology
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
    • Surgery
View Post
  • 14 min
  • Rare Genodermatoses: From Diagnosis to Treatment

Darier’s Disease, also known as Follicular Keratosis – Update 2026

    • CME continuing education
    • Cases
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 7 min
  • Osgood-Schlatter Disease

Clinical Presentation, Diagnosis, and Treatment

    • RX
    • Cases
    • Education
    • Orthopedics
    • Pediatrics
View Post
  • 4 min
  • Cardiovascular Risk in Rheumatoid Arthritis

What is the most dangerous thing for RA?

    • RX
    • Cardiology
    • Education
    • General Internal Medicine
    • Rheumatology
    • Studies
View Post
  • 3 min
  • Antisense oligonucleotide for severe hypertriglyceridemia

Reduced Incidence of Acute Pancreatitis

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 5 min
  • Hereditary Transthyretin Amyloidosis with Polyneuropathy

New Treatment Options for ATTRv-PN

    • RX
    • Cardiology
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 7 min
  • Type 1 Diabetes: A New Disease-Modifying Treatment Approach

Slowing the loss of β-cell function and delaying the progression of the disease

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pediatrics
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Darier’s Disease, also known as Follicular Keratosis – Update 2026
  • 2
    An Enemy in the Microbiome?
  • 3
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
  • 4
    Current status of PAT
  • 5
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.